Pharmacology & ToxicologybioRxivPreprint
ProLung™-budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung Inflammation
K. S. Konduri, R. Pattisapu, J. Pattisapu…·N. Duzgunes
This paper shows ProLung-budesonide inhibits SARS-CoV-2 replication in vitro and reduces lung inflammation and airway hyperresponsiveness in mice.
DOI 10.1101/2021.05.05.442779